TWD 31.15
(-0.16%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 11.72 Billion TWD | 4.7% |
2022 | 11.2 Billion TWD | 8.59% |
2021 | 10.31 Billion TWD | -0.58% |
2020 | 10.37 Billion TWD | 18.87% |
2019 | 8.72 Billion TWD | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q2 | 12.06 Billion TWD | 0.67% |
2024 Q1 | 11.98 Billion TWD | 2.22% |
2023 Q3 | 11.33 Billion TWD | -9.72% |
2023 Q2 | 12.55 Billion TWD | 10.12% |
2023 FY | 11.72 Billion TWD | 4.7% |
2023 Q1 | 11.4 Billion TWD | 0.0% |
2023 Q4 | 11.72 Billion TWD | 3.47% |
2022 Q4 | - TWD | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Allied Biotech Corporation | 2.07 Billion TWD | -464.172% |
GeneFerm Biotechnology Co., Ltd. | 1.17 Billion TWD | -897.859% |
Easywell Biomedicals, Inc. | 1.21 Billion TWD | -866.283% |
TTY Biopharm Company Limited | 9.87 Billion TWD | -18.772% |
Orient EuroPharma Co., Ltd. | 10.81 Billion TWD | -8.48% |
Center Laboratories, Inc. | 27 Billion TWD | 56.564% |
Tien Liang BioTech Co., Ltd. | 654.03 Million TWD | -1693.266% |
Orient Pharma Co., Ltd. | 2.56 Billion TWD | -357.67% |
InnoPharmax Inc. | 524.19 Million TWD | -2137.443% |
Johnson Chemical Pharmaceutical Works Co., Ltd. | 1.99 Billion TWD | -488.506% |
Excelsior Biopharma Inc. | 1.57 Billion TWD | -643.573% |
DV Biomed Co., Ltd. | 1.81 Billion TWD | -547.042% |
Foresee Pharmaceuticals Co., Ltd. | 1.86 Billion TWD | -530.08% |
Handa Pharmaceuticals, Inc. | 3.03 Billion TWD | -286.166% |
UniPharma Co., Ltd. | 350.07 Million TWD | -3250.317% |
Anxo Pharmaceutical Co., Ltd. | 2.21 Billion TWD | -428.654% |
Alar Pharmaceuticals Inc. | 973.2 Million TWD | -1105.149% |
Winston Medical Supply Co., Ltd. | 801.77 Million TWD | -1362.826% |
Mercury Biopharmaceutical Corporation | 438.07 Million TWD | -2577.301% |
Bioray Biotech Co., Ltd | 542.64 Million TWD | -2061.362% |
TSH Biopharm Corporation Limited | 1.39 Billion TWD | -737.841% |